...was the fact that we we never informed of this "court" occurence going on...that to me should have, at the minimum, been conveyed to us in the Risk Factors of the Q's and K's. Imagine the angst here among the shareholders if we knew nothing of the PTO ongoings, which have always been conveyed to us in some manner, until they have been concluded.

RG calls it "similar" to the PTO reexam...IMHO I disagree...what it is most similar to, at least to me, was a Markman Hearing....and you only have one of those if there is a court case ongoing...it may be different in Germany, but what occurred there was more significant than a reexam by one examiner at the PTO IMO.

As always I (we) now have the feeling that there are other 'agendas" in process that we may never hear of till the conclusion of them....that is no way to get the public, let alone private investors to buy in.

RG, now that the verdict is in on the patents validity in Germany, really couldn't say much more...maybe a rah-rah type of sentence of a positive nature but not much more...the other info was okay...and appreciated....but I will from now on wonder who on the inside knows what and what is being held back from us...even while they trade the shares with this knowledge....seems more and more like we, the common shareholders, are forever being overlooked.

Obviously, I am totally disappointed with management and the BOD along with TPL for this exclusion....and I hope to never again read about something this important, not only at it's conclusion, but on a PR ...AFTER... one of us has to make it public.

Things had better start to change..starting immediately.

JMHO